Edgar Cheng - Concepedia

Author

Edgar Cheng

Memorial Sloan Kettering Cancer Center

Also Known As

E Cheng, E W Cheng, Edgar Cheng, Edgar W. Cheng, Edgar W. K. Cheng, Emilie Cheng

Publications

831

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University

About

Edgar Cheng is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	412
2	Pathology	10	10	339
3	Gastroenterology	2	2	30
4	Health Sciences	1	1	22
5	Hepatology	1	1	10

Edgar Cheng

Publications

714

Citations

H-Index

Page 1

	Year	Citations
Trabecular (merkel cell) carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease John H. Raaf, Carlos Urmacher, William K. Knapper, Cancer Surgical OncologyMerkel CellNew PatientsMalignant DiseaseMedicine	1986	164
Germ cell tumors (II). VAB II in metastatic testicular cancer Edgar Cheng, Esteban Cvitkovic, Robert E. Wittes, Cancer	1978	98
VAB–4 combination chemotherapy in the treatment of metastatic testis tumors Davor Vugrin, Esteban Cvitkovic, Willet F. Whitmore, Cancer	1981	93
VAB-3 combination chemotherapy of metastatic testicular cancer Thomas F. Reynolds, Davor Vugrin, Esteban Cvitkovic, Cancer	1981	71
Spontaneous Pneumothorax as a Result of Intensive Cytotoxic Chemotherapy Philip Schulman, Edgar Cheng, Esteban Cvitkovic, CHEST Journal Surgical OncologyPneumothoraxMedicinePleural DiseaseThoracic Surgery	1979	51
Phase II trial of cisplatin (CPDD) in previously treated patients with advanced soft tissue sarcoma Joseph Brenner, Gordon B. Magill, Peter P. Sordillo, Cancer UrologyPhase Ii TrialMalignant DiseaseMedicineSurgical Pathology	1982	32
Pharmacokinetics of cisplatin regional hepatic infusions David P. Kelsen, John L. Hoffman, Nancy W. Alcock, American Journal of Clinical Oncology	1982	27
Vindesine in the treatment of malignant mesothelioma: a phase II study. David P. Kelsen, R. Gralla, Edgar Cheng, PubMed Medicinal ChemistrySurgical OncologyOncologyPeripheral NeuropathyMalignant Mesothelioma	1983	27
Phase II trial of etoposide in APUD tumors. David P. Kelsen, J. Fiore, R T Heelan, PubMed Neuro-oncologyEndocrine OncologyApud TumorsSingle AgentMedicine	1987	23
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer. David P. Kelsen, R. Gralla, Mark Stoopler, PubMed Toxic EffectsCancer ManagementPharmacotherapyMetronomic ChemotherapyCancer Chemotherapy	1982	22

Page 1